Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 18, 2012

Primary Completion Date

December 12, 2019

Study Completion Date

December 12, 2019

Conditions
Chronic Kidney DiseaseEnd Stage Renal DiseaseAnemia
Interventions
DRUG

Roxadustat

Oral capsule

Trial Locations (7)

20770

Greenbelt

28801

Mountain Kidney & HTN Associates, PA, Asheville

76015

Arlington Nephrology, Arlington

92505

APEX Research, Riverside

00725

Consolidated Medical Plaza, Caguas

00716

CAIMED School of Medicine, Ponce

00918

San Juan

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Astellas Pharma Inc

INDUSTRY

lead

FibroGen

INDUSTRY